Agenda Wednesday August 9, 2023
Longeveron (NASDAQ: LGVN) is a clinical stage biotechnology company developing regenerative medicines to address unmet medical needs. The Company’s lead investigational product is Lomecel-B™ an allogeneic medicinal signaling cell (MSC) therapy product isolated from the bone marrow of young, healthy adult donors.
Keynote speaker: Mohamed Wa’el Ahmed Hashad, CEO & Director
ASP Isotopes, Inc. (NASDAQ: ASPI) is an advanced materials company dedicated to developing technology and processes to produce isotopes in multiple industries. The Company employs proprietary technology, the Aerodynamic Separation Process (“ASP technology”), for the production, distribution, marketing, and sale of all isotopes.
Keynote speaker: Paul Elliot Mann, CEO & Chairman
Alpha Tau Medical, Ltd. (NASDAQ: DRTS, DRTSW) is an Israeli medical device company that focuses on research, development, and potential commercialization of the Alpha DaRT for the treatment of solid tumors. The technology was initially developed by Prof. Itzhak Kelson and Prof. Yona Keisari from Tel Aviv University.
Keynote speaker: Raphi Levy, CFO
Kintara Therapeutics, Inc. (NASDAQ: KTRA) is dedicated to the development of novel cancer therapies for patients with unmet medical needs. Kintara is developing two late-stage therapeutics for clear unmet medical needs with reduced risk development programs. The two programs are VAL-083 for glioblastoma (GBM) and REM-001 Therapy for cutaneous metastatic breast cancer (CMBC).
Keynote speaker: Robert Hoffman CEO
Sigyn Therapeutics, Inc. (OTCQB: SIGY) creates therapeutic blood purification candidates to overcome clearly defined limitations in healthcare. The Company’s leadership team has extensive public market and medical technology experience, which includes multiple first-in-industry achievements.
Keynote speaker: James Allen Joyce, CEO
dynaCERT Inc. (OTCQB: DYFSF) (TSX: DYA) manufactures and distributes Carbon Emission Reduction Technology along with its proprietary HydraLytica™ Telematics, a means of monitoring fuel consumption and calculating GHG emissions savings designed for the tracking of possible future Carbon Credits for use with internal combustion engines.
Keynote speaker: James Payne President / CEO & Director
Willow Biosciences, Inc. (OTCQB: CANSF) (TSX: WLLW) develops and produces precision fermented functional ingredients for the health and wellness, food and beverage and personal care markets. Willow’s FutureGrown™ and BioOxi™ platforms enable large-scale production with sustainability at its core.
Keynote speaker: Dr. Chris Savile, President / CEO
Intellabridge Technology Corporation (OTCQB: KASHF) (CSE: KASH) (FSE: KASH) is a fintech company in the business of impact finance with a mission to make every transaction have a positive impact on the world through cashback solutions and automated customizable donations to charitable organizations based on the United Nations Sustainable Development Goals.
Keynote speaker: John Eagleton, CEO
Agenda Thursday August 10, 2023
Jaguar Health, Inc. (NASDAQ: JAGX) is a commercial stage pharmaceuticals company focused on developing novel, plant-based, sustainably derived prescription medicines for people and animals with GI distress, including chronic, debilitating diarrhea.
Keynote speaker: Lisa A. Conte, Founder / CEO / President & Director
Regen BioPharma Inc. (OTC Pink: RGBP) is a biotechnology company focused on developing innovative treatments using autologous cell therapies, RNA and DNA-based immunotherapy and small molecules in the immune-oncology and autoimmune disease space.
Keynote speaker: David Koos, President / CEO & Harry M. Lander, Ph.D. Senior Scientific Consultant
Big Screen (OTC Pink: BSEG) now in its 18th year, is a cutting-edge development, production and distribution company based in Los Angeles, dedicated to bringing captivating stories to life on the big and small screens.
Keynote speaker: Kimberely Kates, CEO
Renforth Resources, Inc. (OTCQB: RFHRF) (CSE: RFR) is a secure multi-commodity area play with the dominant brownfield land position south of the world class Cadillac-Larder Lake Fault (“CLLF”) in the prolific Cadillac and Malartic mining camps of Quebec’s Abitibi. Offering exposure to gold, zinc, nickel, copper, cobalt and more, including lithium, Renforth’s land position encompasses several areas of interest.
Keynote speaker: Nicole Brewster, President & CEO
ClearOne (NASDAQ: CLRO) is a global market leader enabling conferencing, collaboration, and network streaming solutions. The performance and simplicity of its advanced, comprehensive solutions offer unprecedented levels of functionality, reliability, and scalability.
Keynote speaker: Derek Graham, CEO & Narsi Narayanan, CFO
Can-Fite BioPharma Ltd. (NYSE American: CANF) (TASE: CANF) is an advanced clinical stage drug development company with a platform technology that is designed to address multi-billion dollar markets in the treatment of cancer, liver, and inflammatory disease.
Keynote speaker: Motti Farbstein, COO & CFO
Kodiak Copper Corp. (OTCQB: KDKCF) (TSXV: KDK) (FSE: 5DD1) is focused on its 100% owned copper porphyry projects in Canada and the USA. The Company’s most advanced asset is the MPD copper-gold porphyry project in the prolific Quesnel Trough in south-central British Columbia, Canada. MPD has all the hallmarks of a large, multi-centered porphyry system.
Keynote speaker: Claudia Tornquist, CEO
The Emerging Growth Conference focus and coverage includes a wide range of growth sectors and timely market themes, including, augmented reality, artificial intelligence, scientific, medical instruments and therapeutics, biotechnologies, cannabis, food & beverage, energy and more.
Our conference serves as a vehicle for Emerging Growth to build relationships with our existing and potential clients. Accordingly, a certain number of the presenting companies are our current clients, and some may become our clients in the future. In exchange for services we provide, our clients pay us fees in the form of cash and securities, and we may currently have, or in the future may have investments in the securities of certain of the presenting companies. Finally, certain of the presenting companies have paid us a fee to secure a presentation time slot or to present generally.
The presentations to be delivered by the presenting companies (including any handouts of written materials) have not been approved, endorsed by or otherwise reviewed by EmergingGrowth.com nor should they in any way be construed to have been made in connection with the offer to sell or a solicitation of an offer to buy securities. Please consult an investment professional before investing in anything viewed on the Emerging Growth Conference or on EmergingGrowth.com.
Thank you for your interest in our conference, and we look forward to your participation in future conferences.
